J&J's bid to change pay model for Stelara, Xarelto slammed

[cafead]

via A US government agency has hit back at a plan by Johnson & Johnson to change the way it pays discounts on drugs to hospitals participating in the 340B program for healthcare systems serving vulnerable populations.

article source